8C41 image
Deposition Date 2022-12-30
Release Date 2024-01-10
Last Version Date 2025-07-23
Entry Detail
PDB ID:
8C41
Keywords:
Title:
High resolution structure of the Streptococcus pneumoniae topoisomerase IV-DNA complex with the novel fluoroquinolone Delafloxacin
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.39 Å
R-Value Free:
0.24
R-Value Work:
0.19
Space Group:
P 31 2 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Fused ParE30ParC55 CLEAVAGE COMPLEX of the TOPOISOMERASE IV
Mutagens:Insertion of His at postion 648
Chain IDs:A, B
Chain Length:742
Number of Molecules:2
Biological Source:Streptococcus pneumoniae
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (5'-D(*CP*AP*TP*GP*AP*AP*T)-3')
Chain IDs:C (auth: E)
Chain Length:7
Number of Molecules:1
Biological Source:DNA molecule
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (5'-D(P*AP*GP*TP*CP*AP*TP*TP*CP*AP*TP*G)-3')
Chain IDs:D (auth: F)
Chain Length:11
Number of Molecules:1
Biological Source:DNA molecule
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (5'-D(*CP*GP*TP*GP*CP*AP*T)-3')
Chain IDs:E (auth: G)
Chain Length:7
Number of Molecules:1
Biological Source:DNA molecule
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (5'-D(P*GP*AP*CP*TP*AP*TP*GP*CP*AP*CP*G)-3')
Chain IDs:F (auth: H)
Chain Length:11
Number of Molecules:1
Biological Source:DNA molecule
Primary Citation
Structural basis of topoisomerase targeting by delafloxacin.
Nat Commun 16 5829 5829 (2025)
PMID: 40595483 DOI: 10.1038/s41467-025-60688-3

Abstact

Delafloxacin is a potent anionic fluoroquinolone approved for the treatment of respiratory infections that acts by trapping the DNA cleavage complexes of bacterial topoisomerase IV and gyrase. Its N-1-pyridinyl-, C-7-azetidinyl- and C-8-chlorine substituents confer enhanced antibiotic activity against bacteria resistant to other fluoroquinolones, but its mode of action is unclear. Here we present the X-ray crystal structures of a delafloxacin-DNA cleavage complex obtained by co-crystallization with Streptococcus pneumoniae topo IV using a graphene nucleant and solved at 2.0 and 2.4 Å resolution. The two Mg2+-chelated delafloxacin molecules intercalated at the DNA cleavage site are bound in an unusual conformation involving interacting out-of-plane N-1-aromatic- and C-8-chlorine- substituents. The unprecedented resolution allows comprehensive imaging of water-metal ion links integrating enzyme and DNA through drug-bound and active-site Mg2+ ions plus the discovery of enzyme-bound K+ ions. Our studies on delafloxacin action suggest that intrinsic target affinity contributes to its activity against quinolone-resistant bacteria.

Legend

Protein

Chemical

Disease

Primary Citation of related structures